Literature DB >> 28051004

Adopting ORCID as a unique identifier will benefit all involved in scholarly communication.

Subbiah Arunachalam1, Muthu Madhan2.   

Abstract

ORCID, the Open Researcher and Contributor ID, is a non- profit, community-driven effort to create and maintain a registry of unique researcher identifiers and a transparent method of linking research activities and outputs to these identifiers. Together with other persistent identifiers for scholarly works such as digital object identifiers (DOIs) and identifiers for organizations, ORCID makes research more discoverable. It helps ensure that one's grants, publications and outputs are correctly attributed. It helps the research community not just in aggregating publications, but in every stage of research, viz. publishing, reviewing, profiling, metrics, accessing and archiving. Funding agencies in Austria, Australia, Denmark, Portugal, Sweden and the UK, and the world's leading scholarly publishers and associations have integrated their systems with ORCID registry. Among the BRICS countries, China and South Africa are adopting ORCID avidly. India is yet to make a beginning. If research councils and funding agencies in India require researchers to adopt ORCID and link ORCID iDs to funding as well as tracking performance, it will help them keep track of the workflow. Journal editors can also keep track of contributions made by different authors and work assigned to different reviewers through their ORCID iDs.

Mesh:

Year:  2016        PMID: 28051004

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  2 in total

1.  Scientific authorship: a primer for researchers.

Authors:  Olena Zimba; Armen Yuri Gasparyan
Journal:  Reumatologia       Date:  2020-12-23

Review 2.  Researcher and Author Profiles: Opportunities, Advantages, and Limitations.

Authors:  Armen Yuri Gasparyan; Bekaidar Nurmashev; Marlen Yessirkepov; Dmitry A Endovitskiy; Alexander A Voronov; George D Kitas
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.